Xcout Intel
Microbion Corp
Microbion Corp is a clinical-stage pharmaceutical company dedicated to developing novel therapeutic solutions for serious, resistant infections. The organization focuses on building world-class capabilities to help patients in need.
Subscribe to see Microbion Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Microbion Corp at a glance
Microbion Corp is a company headquartered in United States. It has raised at least $29.5M across the 2 funding rounds on record. Its most recent funding round raised $4.1M in January 2021. Xcout tracks 8 named people at Microbion Corp, including Steve Schellong (CEO).
Microbion Corp leadership
- Steve SchellongCEO
- Jeff MillardChief Scientific Officer
- Brett BakerFounder, President & Chief Innovation Officer
- Muhammad MemonDirector of Finance
- Robert GillamChairman
- Jason J HarmonDirector
2 more named people on record for Microbion Corp, with roles, board committees and tenure — see the full roster →
Microbion Corp funding rounds
At least $29.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $4.1M | — | |
| SEC Form D filing | $25.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Microbion Corp competitors
A few of Microbion Corp's closest competitors — see the full list of competitors and alternatives →
Micron Biomedical, Inc. is a clinical-stage biopharmaceutical and life science company committed to expanding global access to therapeutics and vaccines formulated into proprietary array-based delivery technologies.
Melinta Therapeutics, Inc. is a U.S. pharmaceutical company focused on developing and commercializing antibiotics and other therapies for serious bacterial infections. Its products primarily serve hospitals, infectious-disease specialists, and other healthcare providers treating patients with acute or drug-resistant infections.
C3J Therapeutics, Inc. is a clinical-stage biotechnology company based in Los Angeles, California, focused on improving human health through the development of targeted antimicrobials.
NanoBio Corp. is a biopharmaceutical company based in Ann Arbor, Michigan, focused on developing dermatological products and anti-infective treatments.
MarvelBiome, Inc. is a clinical-stage biopharmaceutical company headquartered in Woburn, Massachusetts, focused on harnessing the power of microbes to treat human diseases.
MycoRx LLC develops new antifungal drug candidates designed to overcome drug resistance and treat fungal infections ranging from recurrent skin conditions to life-threatening sepsis. The company also supports clinical trials for other drug developers and maintains safety standards in the testing and manufacturing of pharmaceutical products.
Get Microbion Corp's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Microbion Corp in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access